Pseudomonas Aeruginosa Theft Biofilm Require Host Lipids of Cutaneous Wound

Objective: This work addressing complexities in wound infection, seeks to test the reliance of bacterial pathogen Pseudomonas aeruginosa (PA) on host skin lipids to form biofilm with pathological consequences. Background: PA biofilm causes wound chronicity. Both CDC as well as NIH recognizes biofilm infection as a threat leading to wound chronicity. Chronic wounds on lower extremities often lead to surgical limb amputation. Methods: An established preclinical porcine chronic wound biofilm model, infected with PA or Pseudomonas aeruginosa ceramidase mutant (PA∆Cer), was used. Results: We observed that bacteria drew resource from host lipids to induce PA ceramidase expression by three orders of magnitude. PA utilized product of host ceramide catabolism to augment transcription of PA ceramidase. Biofilm formation was more robust in PA compared to PA∆Cer. Downstream products of such metabolism such as sphingosine and sphingosine-1-phosphate were both directly implicated in the induction of ceramidase and inhibition of peroxisome proliferator-activated receptor (PPAR)δ, respectively. PA biofilm, in a ceram-idastin-sensitive manner, also silenced PPARδ via induction of miR-106b. Low PPARδ limited ABCA12 expression resulting in disruption of skin lipid homeostasis. Barrier function of the wound-site was thus compromised. Conclusions: This work demonstrates that microbial pathogens must co-opt host skin lipids to unleash biofilm pathogenicity. Anti-biofilm strategies must not necessarily always target the microbe and targeting host lipids at risk of infection could be productive. This work may be viewed as a first step, laying fundamental mechanistic groundwork, toward a paradigm change in biofilm management.

[1]  E. Gulbins,et al.  Sphingosine kills bacteria by binding to cardiolipin , 2020, The Journal of Biological Chemistry.

[2]  D. McComb,et al.  Novel Bacterial Diversity and Fragmented eDNA Identified in Hyperbiofilm-Forming Pseudomonas aeruginosa Rugose Small Colony Variant , 2020, iScience.

[3]  J. Buer,et al.  Sphingosine is able to prevent and eliminate Staphylococcus epidermidis biofilm formation on different orthopedic implant materials in vitro , 2019, Journal of Molecular Medicine.

[4]  E. Brochiero,et al.  Repair Process Impairment by Pseudomonas aeruginosa in Epithelial Tissues: Major Features and Potential Therapeutic Avenues , 2019, Front. Cell. Infect. Microbiol..

[5]  R. Tuder,et al.  Pseudomonas aeruginosa stimulates nuclear sphingosine-1-phosphate generation and epigenetic regulation of lung inflammatory injury , 2019, Thorax.

[6]  Amitava Das,et al.  Staphylococcus aureus Biofilm Infection Compromises Wound Healing by Causing Deficiencies in Granulation Tissue Collagen , 2019, Annals of surgery.

[7]  K. Ekroos,et al.  Untargeted lipidomic analysis to broadly characterize the effects of pathogenic and non-pathogenic staphylococci on mammalian lipids , 2018, PloS one.

[8]  S. Symes,et al.  Pseudomonas aeruginosa responds to exogenous polyunsaturated fatty acids (PUFAs) by modifying phospholipid composition, membrane permeability, and phenotypes associated with virulence , 2018, BMC Microbiology.

[9]  Simon C Watkins,et al.  Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium , 2018, The Journal of clinical investigation.

[10]  C. Sen,et al.  Staphylococcus aureus biofilms release leukocidins to elicit extracellular trap formation and evade neutrophil-mediated killing , 2018, Proceedings of the National Academy of Sciences.

[11]  S. Gnyawali,et al.  Epigenetic Modification of MicroRNA-200b Contributes to Diabetic Vasculopathy. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Savita Khanna,et al.  Electric Field Based Dressing Disrupts Mixed-Species Bacterial Biofilm Infection and Restores Functional Wound Healing , 2017, Annals of surgery.

[13]  R. Hartmann,et al.  In-depth Profiling of MvfR-Regulated Small Molecules in Pseudomonas aeruginosa after Quorum Sensing Inhibitor Treatment , 2017, Front. Microbiol..

[14]  N. Høiby,et al.  Biofilms and host response – helpful or harmful , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[15]  B. V. Van Tassell,et al.  Unsupervised analysis of combined lipid and coagulation data reveals coagulopathy subtypes among dialysis patients[S] , 2017, Journal of Lipid Research.

[16]  N. Okino,et al.  Molecular mechanism for sphingosine-induced Pseudomonas ceramidase expression through the transcriptional regulator SphR , 2016, Scientific Reports.

[17]  L. Rahme,et al.  A Quorum Sensing Signal Promotes Host Tolerance Training Through HDAC1-Mediated Epigenetic Reprogramming , 2016, Nature Microbiology.

[18]  J. Benach,et al.  Hijacking and Use of Host Lipids by Intracellular Pathogens. , 2015, Microbiology spectrum.

[19]  Boo Shan Tseng,et al.  Pel is a cationic exopolysaccharide that cross-links extracellular DNA in the Pseudomonas aeruginosa biofilm matrix , 2015, Proceedings of the National Academy of Sciences.

[20]  H. Elgharably,et al.  Mixed‐species biofilm compromises wound healing by disrupting epidermal barrier function , 2014, The Journal of pathology.

[21]  X. Deng,et al.  Molecular mechanisms of master regulator VqsM mediating quorum-sensing and antibiotic resistance in Pseudomonas aeruginosa , 2014, Nucleic acids research.

[22]  K. Rumbaugh Genomic complexity and plasticity ensure Pseudomonas success. , 2014, FEMS microbiology letters.

[23]  Cristina Solano,et al.  Biofilm dispersion and quorum sensing. , 2014, Current opinion in microbiology.

[24]  J. Woodfolk,et al.  Skin Barrier Defects in Atopic Dermatitis , 2014, Current Allergy and Asthma Reports.

[25]  P. Elias,et al.  Role of lipids in the formation and maintenance of the cutaneous permeability barrier. , 2014, Biochimica et biophysica acta.

[26]  M. Akiyama The roles of ABCA12 in epidermal lipid barrier formation and keratinocyte differentiation. , 2014, Biochimica et biophysica acta.

[27]  M. Manefield,et al.  Pyocyanin Facilitates Extracellular DNA Binding to Pseudomonas aeruginosa Influencing Cell Surface Properties and Aggregation , 2013, PloS one.

[28]  R. Kirsner,et al.  Preclinical Models of Wound Healing: Is Man the Model? Proceedings of the Wound Healing Society Symposium. , 2013, Advances in wound care.

[29]  K. Mathee,et al.  A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence , 2012, Nucleic acids research.

[30]  Stephen Lory,et al.  The Single-Nucleotide Resolution Transcriptome of Pseudomonas aeruginosa Grown in Body Temperature , 2012, PLoS pathogens.

[31]  Y. Hannun,et al.  Ceramide synthases at the centre of sphingolipid metabolism and biology. , 2012, The Biochemical journal.

[32]  L. Beck,et al.  Skin Barrier Disruption - A Requirement for Allergen Sensitization? , 2011, The Journal of investigative dermatology.

[33]  S. Dowd,et al.  The Role of Biofilms: Are We Hitting the Right Target? , 2011, Plastic and reconstructive surgery.

[34]  J. Olerud,et al.  Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds , 2010, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[35]  T. Tolker-Nielsen,et al.  Nonrandom Distribution of Pseudomonas aeruginosa and Staphylococcus aureus in Chronic Wounds , 2009, Journal of Clinical Microbiology.

[36]  P. Elias,et al.  Ceramide Stimulates ABCA12 Expression via Peroxisome Proliferator-activated Receptor δ in Human Keratinocytes* , 2009, The Journal of Biological Chemistry.

[37]  M. Kawada,et al.  Ceramidastin, a novel bacterial ceramidase inhibitor, produced by Penicillium sp. Mer-f17067 , 2009, The Journal of Antibiotics.

[38]  T. Agner,et al.  Lipids and skin barrier function – a clinical perspective , 2008, Contact dermatitis.

[39]  K. Feingold The role of epidermal lipids in cutaneous permeability barrier homeostasis , 2007 .

[40]  A. Jesaitis,et al.  Compromised Host Defense on Pseudomonas aeruginosa Biofilms: Characterization of Neutrophil and Biofilm Interactions 1 , 2003, The Journal of Immunology.

[41]  R. Kolesnick,et al.  Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts , 2003, Nature Medicine.

[42]  J. Costerton,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.

[43]  B. Iglewski,et al.  Quorum-Sensing Genes in Pseudomonas aeruginosa Biofilms: Their Role and Expression Patterns , 2001, Applied and Environmental Microbiology.

[44]  S. Imayama,et al.  Ceramidase Activity in Bacterial Skin Flora as a Possible Cause of Ceramide Deficiency in Atopic Dermatitis , 1999, Clinical Diagnostic Laboratory Immunology.

[45]  H. Shinefield,et al.  Antimicrobial activity of sphingosines. , 1992, The Journal of investigative dermatology.

[46]  S. Fowler,et al.  Nile red: a selective fluorescent stain for intracellular lipid droplets , 1985, The Journal of cell biology.

[47]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[48]  Yutong Zhao,et al.  Epigenetic regulation of pro-inflammatory cytokine secretion by sphingosine 1-phosphate (S1P) in acute lung injury: Role of S1P lyase , 2017 .

[49]  P. Elias,et al.  PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. , 2008, The Journal of investigative dermatology.

[50]  T. Willson,et al.  Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. , 2004, The Journal of investigative dermatology.

[51]  A. Maza,et al.  Ceramides and Skin Function , 2003, American journal of clinical dermatology.

[52]  P. Borst,et al.  Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.